Celcuity (NASDAQ: CELC) insider transactions
In the twelve months to 10 November 2026, executives and directors of Celcuity reported 17 open-market sales of 3,180,000 shares ($327.6m) and 0 open-market purchases, by 3 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 7 October 2026 | Furcht Leo | Director | Option exercise | +250 | $7.60 | 12,780 | Form 4 |
| 1 October 2026 | Gryska David W | Director | Grant or award | +893 | — | 893 | Form 4 |
| 14 August 2026 | Sullivan Brian F. | Chief Executive Officer | Grant or award | +80,000 | — | 1,450,199 | Form 4 |
| 14 August 2026 | Laing Lance G. | Chief Science Officer | Grant or award | +20,000 | — | 1,271,000 | Form 4 |
| 14 August 2026 | Hahne Vicky | Chief Financial Officer | Grant or award | +16,000 | — | 37,808 | Form 4 |
| 14 July 2026 | Baker Julian | — | Open-market sale | −261,368 | $102.50 | 442,940 | Form 4 |
| 14 July 2026 | Baker Julian | — | Open-market sale | −2,838,632 | $102.50 | 4,372,852 | Form 4 |
| 5 June 2026 | Nigon Richard | Director | Grant or award | +1,530 | — | 80,565 | Form 4 |
| 5 June 2026 | Dalvey David | Director | Grant or award | +1,530 | — | 1,530 | Form 4 |
| 5 June 2026 | Buller Richard E | Director | Grant or award | +1,530 | — | 1,530 | Form 4 |
| 5 June 2026 | Furcht Leo | Director | Grant or award | +1,530 | — | 12,530 | Form 4 |
| 5 June 2026 | Romp Charles R | Director | Grant or award | +1,530 | — | 1,745 | Form 4 |
| 5 June 2026 | Murphy Polly A. | Director | Grant or award | +1,530 | — | 6,530 | Form 4 |
| 2 June 2026 | Laing Lance G. | Chief Science Officer | Option exercise | +1,000 | $9.89 | 1,251,000 | Form 4 |
| 19 May 2026 | Buller Richard E | Director | Gift | −1,029 | — | 0 | Form 4 |
| 19 May 2026 | Buller Richard E | Director | Gift | +1,029 | — | 7,789 | Form 4 |
| 4 May 2026 | Dalvey David | Director | Open-market sale, 10b5-1 plan | −25,000 | $140.68 | 65,000 | Form 4 |
| 4 May 2026 | Buller Richard E | Director | Option exercise, 10b5-1 plan | +9,000 | $5.10 | 15,760 | Form 4 |
| 4 May 2026 | Buller Richard E | Director | Open-market sale, 10b5-1 plan | −1,289 | $137.00 | 14,471 | Form 4 |
| 4 May 2026 | Buller Richard E | Director | Open-market sale, 10b5-1 plan | −550 | $139.00 | 13,921 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Celcuity page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.